HTGM
HTG Molecular Diagnostics, Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Company Profile
CEO
John L. Lubniewski
IPO Date
2015-05-06
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
HTG Molecular Diagnostics, Inc.
CEO
John L. Lubniewski
IPO Date
2015-05-06
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| 1,000 |
| $0.42 |
| 13 Dec 2022 | Godlewski Laura Lee | SVP Finance & Administration | A-Award | Acquired | 1,000 | $0.42 |
| 13 Dec 2022 | Lubniewski John L | President & CEO | A-Award | Acquired | 1,000 | $0.42 |
| 15 Sept 2022 | KIRITSY CHRISTOPHER P | director | A-Award | Acquired | 4,000 | $0.86 |
| 15 Sept 2022 | HARDISON DON M | director | A-Award | Acquired | 4,000 | $0.86 |
| 15 Sept 2022 | HANHAM ANN | director | A-Award | Acquired | 8,000 | $0.86 |
| 15 Sept 2022 | McCracken Lee R. | director | A-Award | Acquired | 4,000 | $0.86 |
| 15 Sept 2022 | GRIFFIN MICHELLE RENEE | director | A-Award | Acquired | 4,000 | $0.86 |
| 22 Aug 2022 | Lawson Byron | SVP/Chief Commercial Officer | A-Award | Acquired | 20,000 | $0.00 |